Ripcord Pharmaceuticals Private Limited, a active private limited company, was established on 21 November 2017 in Kolhapur, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999PN2017PTC173517. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Indu Nimesh Madhu (Director), Mihir Nimesh Madhu (Director), Komal Nimesh Madhu (Director). Past directors included Anand Devichand Shah. It holds ₹1.88 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at F 105, Paraag Complex, 596 E Ward, 1St Lane, Shahupuri ,, Kolhapur, Maharashtra, 416001.
U74999PN2017PTC173517
173517
21 November 2017
₹1.00 Cr
₹5.00 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Ripcord Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Indu Nimesh Madhu | Director | 21 Nov 2017 | Current |
| Mihir Nimesh Madhu | Director | 21 Nov 2017 | Current |
| Komal Nimesh Madhu | Director | 21 Nov 2017 | Current |
| Bhavin Nimesh Madhu | Managing Director | 21 Nov 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 May 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ripcord Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2022, Ripcord Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹18,750,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2019 | Others | ₹1.88 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ripcord Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ripcord Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ripcord Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ripcord Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Ripcord Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune. was recorded as a recent event.
A charge with Others of Rs. 1.88 Cr registered on 09 Mar 2019 with Charge ID 100264706 was modified on 30 Apr 2019. was recorded as a recent event.
A charge with Others amounted to Rs. 1.88 Cr with Charge ID 100264706 was registered on 09 Mar 2019. was recorded as a recent event.
The activity Indu Nimesh Madhu was appointed as a Director was appointed as a Director on 21 Nov 2017 & has been associated with this company since 8 years 28 days . was completed.
Mihir Nimesh Madhu was appointed as a Director was appointed as a Director on 21 Nov 2017 & has been associated with this company since 8 years 28 days . was recorded as a recent event.
The CIN of Ripcord Pharmaceuticals Private Limited is U74999PN2017PTC173517.
Ripcord Pharmaceuticals Private Limited is headquartered at F 105, Paraag Complex, 596 E Ward, 1St Lane, Shahupuri ,, Kolhapur, Maharashtra, 416001.
Ripcord Pharmaceuticals Private Limited was incorporated on 21 November 2017.
The current directors of Ripcord Pharmaceuticals Private Limited are
The primary industry of Ripcord Pharmaceuticals Private Limited is Pharma.
Ripcord Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ripcord Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹5.00 M.
The compliance status of Ripcord Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX